Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

5.200 +0.100 (+1.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 592,164
Open 4.940
Bid (Size) 4.900 (1)
Ask (Size) 5.490 (11)
Prev. Close 5.100
Today's Range 4.740 - 5.200
52wk Range 0.9200 - 5.840
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
From Omeros Corporation
Via Business Wire

Performance

YTD
+58.05%
+58.05%
1 Month
+28.71%
+28.71%
3 Month
+55.69%
+55.69%
6 Month
+34.02%
+34.02%
1 Year
-2.44%
-2.44%

More News

Read More
Crude Oil Moves Higher; Deere Cuts Profit Outlook
Via Benzinga
Exposures Fossil Fuels
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
OMER Stock Earnings: Omeros Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
US Stocks Edge Higher; Initial Jobless Claims Fall
Via Benzinga
Omeros Corporation Reports First Quarter 2024 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
From Omeros Corporation
Via Business Wire
OMER Stock Earnings: Omeros Misses EPS for Q4 2023
Via InvestorPlace
Recap: Omeros Q3 Earnings
Via Benzinga
Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
From Omeros Corporation
Via Business Wire
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
From Omeros Corporation
Via Business Wire
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
Via Benzinga
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
From Omeros Corporation
Via Business Wire
Earnings Scheduled For April 1, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
Via InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
From Omeros Corporation
Via Business Wire
3 Sleeper Stocks Under $15 Ready to Explode by 2029
Via InvestorPlace
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
From Omeros Corporation
Via Business Wire
7 Short-Squeeze Stocks That Are Screaming for Speculation
Via InvestorPlace
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
Via Benzinga
Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.